These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19188824)

  • 21. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
    Niu XY; Feng YK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of HPV DNA Testing in Follow-up after Loop Electrosurgical Excision Procedures in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Kietpeerakool C; Tantipalakorn C; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2015; 16(14):6093-7. PubMed ID: 26320501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study.
    Rabasa J; Bradbury M; Sanchez-Iglesias JL; Guerrero D; Forcada C; Alcalde A; Pérez-Benavente A; Cabrera S; Ramon-Cajal S; Hernandez J; Dinares C; García A; Centeno C; Gil-Moreno A
    BJOG; 2020 Jan; 127(1):99-105. PubMed ID: 31502397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia.
    Kim YT; Lee JM; Hur SY; Cho CH; Kim YT; Kim SC; Kang SB
    Int J Cancer; 2010 Apr; 126(8):1903-1909. PubMed ID: 19642095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins.
    Ayhan A; Tuncer HA; Reyhan NH; Kuscu E; Dursun P
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():1-6. PubMed ID: 27038228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure.
    Cecchini S; Carozzi F; Confortini M; Zappa M; Ciatto S
    Tumori; 2004; 90(2):225-8. PubMed ID: 15237586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human papillomavirus (HPV)-16 or HPV-18 genotype is a reliable predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3.
    Kang WD; Ju UC; Kim SM
    J Gynecol Oncol; 2016 Jan; 27(1):e2. PubMed ID: 26463431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
    Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
    Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure.
    Kang WD; Oh MJ; Kim SM; Nam JH; Park CS; Choi HS
    Am J Obstet Gynecol; 2010 Jul; 203(1):72.e1-6. PubMed ID: 20417477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of recurrent dysplasia after a cervical loop electrocautery excision procedure for CIN-3: a study of margin, endocervical gland, and quadrant involvement.
    Livasy CA; Maygarden SJ; Rajaratnam CT; Novotny DB
    Mod Pathol; 1999 Mar; 12(3):233-8. PubMed ID: 10102607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
    Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative post-conisation human papillomavirus testing for early detection of treatment failure in patients with cervical intraepithelial neoplasia: a pilot study.
    Torné A; Fusté P; Rodríguez-Carunchio L; Alonso I; del Pino M; Nonell R; Cardona M; Rodríguez A; Castillo P; Pahisa J; Balasch J; Ramírez J; Ordi J
    BJOG; 2013 Mar; 120(4):392-9. PubMed ID: 23189989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeat LEEP conization in patients with cervical intraepithelial neoplasia grade 3 and positive ectocervical margins.
    Ayhan A; Boynukalin FK; Guven S; Dogan NU; Esinler I; Usubutun A
    Int J Gynaecol Obstet; 2009 Apr; 105(1):14-7. PubMed ID: 19111301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
    Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia.
    Aerssens A; Claeys P; Beerens E; Garcia A; Weyers S; Van Renterghem L; Praet M; Temmerman M; Velasquez R; Cuvelier CA
    Cytopathology; 2009 Feb; 20(1):27-35. PubMed ID: 18510550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy for management of cervical intraepithelial neoplasia II and III in young patients and obstetric outcomes.
    Choi MC; Jung SG; Park H; Lee SY; Lee C; Hwang YY; Kim SJ
    Lasers Surg Med; 2013 Nov; 45(9):564-72. PubMed ID: 24136239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat low-grade squamous intraepithelial cytology with unsatisfactory colposcopy treated by the loop electrosurgical excision procedure: a retrospective study.
    Liu Y; Li C; Wang J; Zhang W
    Eur J Gynaecol Oncol; 2010; 31(6):632-5. PubMed ID: 21319505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
    Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
    Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
    Kreimer AR; Guido RS; Solomon D; Schiffman M; Wacholder S; Jeronimo J; Wheeler CM; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):908-14. PubMed ID: 16702369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
    Kreimer AR; Katki HA; Schiffman M; Wheeler CM; Castle PE;
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):11-6. PubMed ID: 17220326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.